- Profile
- Personal Information
- Publications
Experts in Oncology
Jairaj K. Acharya Thomas P. Fondy Swarnali Acharyya Bachir Alobeid Richard Baer Aneel K Aggarwal Margaret H Baron Benjamin O. Anderson Parveen Bhatti Marita Zoma Chu Chen Eric Chow Giuseppina Carbone Asma Amleh Katia Basso Govind Bhagat Shiuan Chen Casey L. Daniel WenYong Chen Natalie R. Gassman View MoreSherene Loi, MD, PhD
Head, Translational Breast Cancer Genomics and The
Consultant Medical Oncologist, Breast Unit Peter MacCallum Cancer Centre
University of Melbourne
United Arab Emirates
Dr. Loi's research focuses on developing new therapeutic approaches for breast cancer patients, with a particular interest in the role that the immune environment plays in HER2-positive and triple negative breast cancers. Dr. Loi's research focuses on developing new therapeutic approaches for breast cancer patients, with a particular interest in the role that the immune environment plays in HER2-positive and triple negative breast cancers.
Her team has previously shown that a higher quantity of immune cells called tumor-infiltrating lymphocytes (TILs) present in a breast tumor can predict better survival in some breast cancer patients. These findings suggest that the body's natural immune system can be a critical component in the course of the disease and response to anti-cancer therapies, and that the level of immune cells may provide a clinical biomarker that can identify those patients who will benefit from immunotherapies.